Literature DB >> 12796766

Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation.

Rajendra H Mehta1, Mark A Supiano, Hakan Oral, P Michael Grossman, Daniel S Montgomery, Marla J Smith, Mark R Starling.   

Abstract

BACKGROUND: Whether the systemic sympathetic nervous system is activated as a compensatory mechanism in response to mitral regurgitation (MR) in humans is unknown. We tested the hypotheses that the systemic sympathetic nervous system would be activated in patients with MR in comparison with control subjects and that this activation would occur early in the disease process as a compensatory mechanism for chronic left ventricular (LV) volume overload.
METHODS: We studied 37 patients with MR who underwent right heart catheterization and biplane cineventriculography to obtain LV end-diastolic and end-systolic volumes, ejection fractions, and regurgitant volumes. In these 37 patients with MR and in 23 control subjects, an [(3)H]-norepinephrine ([(3)H]-NE) infusion and multiple arterial blood samples provided data for a 2-compartment modeling analysis to calculate extravascular NE release rates (NE(2)).
RESULTS: The mean NE(2) (2.05 +/- 0.76 microg/min/m(2)) in the patients with MR was greater than that in the control subjects (1.48 +/- 0.75 microg/min/m(2), P =.007). Furthermore, the mean NE(2) values were also greater in the patients with MR who were in clinical class I (P =.05), with a pulmonary capillary wedge pressure <12 mm Hg (P =.05) or a LV ejection fraction >or=0.60 (P =.06) compared with the control subjects. The mean NE(2) values were increased further in patients with MR who had a LV ejection fraction <0.60 (P =.02).
CONCLUSIONS: The systemic sympathetic nervous system is activated in patients with MR in comparison with control subjects, and this activation appears to occur early in the disease process as a compensatory mechanism for LV volume overload.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796766     DOI: 10.1016/S0002-8703(03)00111-X

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Differential Expression of the Angiotensin-(1-12)/Chymase Axis in Human Atrial Tissue.

Authors:  Hao Wang; Jasmina Varagic; Sayaka Nagata; Neal D Kon; Sarfaraz Ahmad; Jessica L VonCannon; Kendra N Wright; Xuming Sun; Dwight Deal; Leanne Groban; Carlos M Ferrario
Journal:  J Surg Res       Date:  2020-04-30       Impact factor: 2.192

2.  A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation.

Authors:  Mustafa I Ahmed; Inmaculada Aban; Steven G Lloyd; Himanshu Gupta; George Howard; Seidu Inusah; Kalyani Peri; Jessica Robinson; Patty Smith; David C McGiffin; Chun G Schiros; Thomas Denney; Louis J Dell'Italia
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

Review 3.  The multiple mechanistic faces of a pure volume overload: implications for therapy.

Authors:  Justin Barnes; Louis J DellʼItalia
Journal:  Am J Med Sci       Date:  2014-10       Impact factor: 2.378

4.  Magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: implications beyond dimensions.

Authors:  Chun G Schiros; Louis J Dell'Italia; James D Gladden; Donald Clark; Inmaculada Aban; Himanshu Gupta; Steven G Lloyd; David C McGiffin; Gilbert Perry; Thomas S Denney; Mustafa I Ahmed
Journal:  Circulation       Date:  2012-04-10       Impact factor: 29.690

5.  Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue.

Authors:  Sayaka Nagata; Jasmina Varagic; Neal D Kon; Hao Wang; Leanne Groban; Stephen W Simington; Sarfaraz Ahmad; Louis J Dell'Italia; Jessica L VonCannon; Dwight Deal; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-06-16

6.  Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.

Authors:  Danielle M Trappanese; Yuchuan Liu; Ryan C McCormick; Alessandro Cannavo; Gayani Nanayakkara; Marina M Baskharoun; Harish Jarrett; Felix J Woitek; D Michael Tillson; A Ray Dillon; Fabio A Recchia; Jean-Luc Balligand; Steven R Houser; Walter J Koch; Louis J Dell'Italia; Emily J Tsai
Journal:  Basic Res Cardiol       Date:  2014-12-06       Impact factor: 17.165

7.  Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation.

Authors:  Junying Zheng; Danielle M Yancey; Mustafa I Ahmed; Chih-Chang Wei; Pamela C Powell; Mayilvahanan Shanmugam; Himanshu Gupta; Steven G Lloyd; David C McGiffin; Chun G Schiros; Thomas S Denney; Gopal J Babu; Louis J Dell'Italia
Journal:  Circ Heart Fail       Date:  2013-12-02       Impact factor: 8.790

8.  Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.

Authors:  Abdelkarim Sabri; Khadija Rafiq; Rachid Seqqat; Mikhail A Kolpakov; Ray Dillon; Louis J Dell'italia
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

9.  Mitral regurgitation: has another magic bullet bitten the dust?

Authors:  Jeffrey S Borer
Journal:  Circ Heart Fail       Date:  2013-07       Impact factor: 8.790

10.  Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.

Authors:  Betty Pat; Cheryl Killingsworth; Thomas Denney; Junying Zheng; Pamela Powell; Michael Tillson; A Ray Dillon; Louis J Dell'Italia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.